TITLE:title
Budget Amendment - Additional Funding for Breast and Cervical Cancer Screening and/or Diagnostic Services
body
INFORMATION CONTACT:
Traci Colley, Human Services Agency, Public Health Department, Director, 704-296-4801
ACTION REQUESTED:
1) Recognize, receive and appropriate $8,125 in additional funding from the North Carolina Division of Public Health, FY25-26 Agreement Addendum 452 Breast and Cervical Cancer; and 2) approve Budget Amendment #17.
PRIOR BOARD ACTIONS:
None.
BACKGROUND:
In the United States, breast cancer is the most commonly diagnosed cancer in women. It is the leading cause of cancer death in Hispanic women and the second most common cause of cancer death among white, black, Asian/Pacific Island, and American Indian/Alaska Native women. In 2021, the U.S. incidence of breast cancer was 129.4 per 100,000 women and the mortality was 19.3 per 100,000 women. In 2024, an estimated 310,720 new cases of invasive breast cancer are expected to be diagnosed among U.S. women, as well as an estimated 56,500 additional cases of in situ breast cancer. In 2024, approximately 42,250 U.S. women are expected to die from breast cancer. Only lung cancer accounts for more cancer deaths. In North Carolina, an estimated 12,724 new female breast cancer cases (in-situ cases included) will be diagnosed in 2024, resulting in 1,544 deaths.
Cervical cancer, once the leading cause of death for women in the U.S., has significantly decreased in incidence and mortality since the mid-1970s due to an increase in Pap tests being conducted. Between 2016 and 2020, the incidence of cervical cancer was 7.7 per 100,000 women. While cervical cancer incidence and mortality continue to decrease, both are considerably higher among Hispanic and non-Hispanic Black women. In 2024, an estimated 13,820 new cases are expected to be diagnosed, with an estimated 4,360 women expected to die from cervical cancer. In North Carolina, an estimated 418 cervical cancer cases will be diagnos...
Click here for full text